Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer — a phase II trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-03

AUTHORS

D Bernardi, R Talamini, M Zanetti, C Simonelli, E Vaccher, M Spina, U Tirelli

ABSTRACT

A total of 28 patients were treated with mitoxantrone, vinorelbine and prednisone every 3 weeks. In all, 11 patients (46%) had a significant prostate-specific antigen decline for a median duration of 11.4 months. Eight patients (33%) achieved a partial response on pain, while seven (29%) obtained a stabilisation of the symptom. Median duration of the response was 9.5 months. A confirmed partial response was obtained in three out of seven patients who had bidimensionally measurable disease. Toxicity was manageable. Our study provides further support to the concept of combined antimicrotubule therapy for metastatic harmonoresistant prostate cancer, promoting the exploration of new regimens containing antimicrotubule agents in addition to mitoxantrone-prednisone. More... »

PAGES

4500685

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.pcan.4500685

DOI

http://dx.doi.org/10.1038/sj.pcan.4500685

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1013727954

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14999238


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Hormonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitoxantrone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vinblastine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vinorelbine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bernardi", 
        "givenName": "D", 
        "id": "sg:person.013501036574.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013501036574.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Epidemiology Unit, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Talamini", 
        "givenName": "R", 
        "id": "sg:person.01233253543.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233253543.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zanetti", 
        "givenName": "M", 
        "id": "sg:person.0624412510.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624412510.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Simonelli", 
        "givenName": "C", 
        "id": "sg:person.0731175270.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731175270.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vaccher", 
        "givenName": "E", 
        "id": "sg:person.011324454444.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011324454444.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spina", 
        "givenName": "M", 
        "id": "sg:person.01314451274.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314451274.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro di Riferimento Oncologico", 
          "id": "https://www.grid.ac/institutes/grid.418321.d", 
          "name": [
            "Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tirelli", 
        "givenName": "U", 
        "id": "sg:person.01244630611.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244630611.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0959-8049(02)00145-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006624855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013578905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-199200444-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020486322", 
          "https://doi.org/10.2165/00003495-199200444-00004"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.10350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021370340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1399-6576.1982.tb01840.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024014172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19930201)71:3+<1098::aid-cncr2820711432>3.0.co;2-g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024352659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0094-0143(05)70066-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025793441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037280810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/canjclin.47.1.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049586839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199104000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049741912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199104000-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049741912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdf029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052208075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008315106697", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008394823889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1011141611560", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056304956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199708000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060113615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199708000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060113615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000421-199708000-00013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060113615"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.11.3461", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074545753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.6.1664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.8.2506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074562608", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074562609", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.9.2509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074807655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079525645", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.4.607", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082464109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1994.12.2.360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082656922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.6.1756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082896530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.9.3156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083145578"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-03", 
    "datePublishedReg": "2004-03-01", 
    "description": "A total of 28 patients were treated with mitoxantrone, vinorelbine and prednisone every 3 weeks. In all, 11 patients (46%) had a significant prostate-specific antigen decline for a median duration of 11.4 months. Eight patients (33%) achieved a partial response on pain, while seven (29%) obtained a stabilisation of the symptom. Median duration of the response was 9.5 months. A confirmed partial response was obtained in three out of seven patients who had bidimensionally measurable disease. Toxicity was manageable. Our study provides further support to the concept of combined antimicrotubule therapy for metastatic harmonoresistant prostate cancer, promoting the exploration of new regimens containing antimicrotubule agents in addition to mitoxantrone-prednisone.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.pcan.4500685", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1119336", 
        "issn": [
          "1365-7852", 
          "1476-5608"
        ], 
        "name": "Prostate Cancer and Prostatic Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer \u2014 a phase II trial", 
    "pagination": "4500685", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4165bde149c39a6275c8fcc9b47c38eda135c977f15577981217ca4f13e94ba6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14999238"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9815755"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.pcan.4500685"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1013727954"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.pcan.4500685", 
      "https://app.dimensions.ai/details/publication/pub.1013727954"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000360_0000000360/records_118309_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/4500685"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500685'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500685'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500685'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500685'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      71 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.pcan.4500685 schema:about N0282b09314a9493fa91c9c6a9fd5a6f1
2 N0df693a162ca47af9d49e353b5c677f8
3 N173b444d0bf0443aafd7343012c37e43
4 N17d92ce2e47f464fb17b494d64826097
5 N4109030ea8f74b209ef1a70fbbab12dc
6 N52689fc5ec114daf814b8ce5cde7c782
7 N55fe287d9e824fc1a62bd55e4d1e1e0c
8 N6425b9f4de144f5faca9b962993409d2
9 N69d19207cfa9473c848290a6c9e17272
10 N73d40e9db5454e7baad92f48375f2ceb
11 N774b086fb95b471ea006f27f71df67cf
12 N7806f4cb234d455a8b420e97c8dab9ba
13 N8ec6c992dd334b83b47fb528f5b9ce1a
14 Nb626f45d44ca4231a2299287ea73d70b
15 Ne1112d56f22a45cda9fbbeeb4951a69b
16 Ne32f8de39c6d4bfdb963a252694bd136
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N53651e6fcbba4a189150e7d5b3f1bcd9
20 schema:citation sg:pub.10.2165/00003495-199200444-00004
21 https://app.dimensions.ai/details/publication/pub.1074562608
22 https://app.dimensions.ai/details/publication/pub.1074562609
23 https://app.dimensions.ai/details/publication/pub.1079525645
24 https://doi.org/10.1002/1097-0142(19930201)71:3+<1098::aid-cncr2820711432>3.0.co;2-g
25 https://doi.org/10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m
26 https://doi.org/10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r
27 https://doi.org/10.1002/cncr.10350
28 https://doi.org/10.1016/s0094-0143(05)70066-5
29 https://doi.org/10.1016/s0959-8049(02)00145-4
30 https://doi.org/10.1023/a:1008315106697
31 https://doi.org/10.1023/a:1008394823889
32 https://doi.org/10.1023/a:1011141611560
33 https://doi.org/10.1093/annonc/mdf029
34 https://doi.org/10.1097/00000421-199104000-00004
35 https://doi.org/10.1097/00000421-199708000-00013
36 https://doi.org/10.1111/j.1399-6576.1982.tb01840.x
37 https://doi.org/10.1200/jco.1993.11.4.607
38 https://doi.org/10.1200/jco.1994.12.2.360
39 https://doi.org/10.1200/jco.1996.14.6.1756
40 https://doi.org/10.1200/jco.1997.15.9.3156
41 https://doi.org/10.1200/jco.1999.17.11.3461
42 https://doi.org/10.1200/jco.1999.17.6.1664
43 https://doi.org/10.1200/jco.1999.17.8.2506
44 https://doi.org/10.1200/jco.2001.19.9.2509
45 https://doi.org/10.3322/canjclin.47.1.5
46 schema:datePublished 2004-03
47 schema:datePublishedReg 2004-03-01
48 schema:description A total of 28 patients were treated with mitoxantrone, vinorelbine and prednisone every 3 weeks. In all, 11 patients (46%) had a significant prostate-specific antigen decline for a median duration of 11.4 months. Eight patients (33%) achieved a partial response on pain, while seven (29%) obtained a stabilisation of the symptom. Median duration of the response was 9.5 months. A confirmed partial response was obtained in three out of seven patients who had bidimensionally measurable disease. Toxicity was manageable. Our study provides further support to the concept of combined antimicrotubule therapy for metastatic harmonoresistant prostate cancer, promoting the exploration of new regimens containing antimicrotubule agents in addition to mitoxantrone-prednisone.
49 schema:genre research_article
50 schema:inLanguage en
51 schema:isAccessibleForFree true
52 schema:isPartOf N7ff87d72a21b4c47b446c6d683f06d71
53 N827b0a6010e94897b0091c3c89c9568c
54 sg:journal.1119336
55 schema:name Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer — a phase II trial
56 schema:pagination 4500685
57 schema:productId N04266724f129467c9b1b9c4210e5242c
58 N2d38fa66b3e44643b7e55e7fed8a0de9
59 N4f7075628f7f4124989e136ac17580eb
60 Ne68fd385e4fa48ed9f6830302d4468cf
61 Nf1989256172f465186e978f76bc6f790
62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013727954
63 https://doi.org/10.1038/sj.pcan.4500685
64 schema:sdDatePublished 2019-04-11T12:03
65 schema:sdLicense https://scigraph.springernature.com/explorer/license/
66 schema:sdPublisher Nd93c04cc36a0482d862fdc48fdd7bd75
67 schema:url http://www.nature.com/articles/4500685
68 sgo:license sg:explorer/license/
69 sgo:sdDataset articles
70 rdf:type schema:ScholarlyArticle
71 N0282b09314a9493fa91c9c6a9fd5a6f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Aged
73 rdf:type schema:DefinedTerm
74 N04266724f129467c9b1b9c4210e5242c schema:name doi
75 schema:value 10.1038/sj.pcan.4500685
76 rdf:type schema:PropertyValue
77 N0df693a162ca47af9d49e353b5c677f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Antineoplastic Agents, Hormonal
79 rdf:type schema:DefinedTerm
80 N173b444d0bf0443aafd7343012c37e43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Middle Aged
82 rdf:type schema:DefinedTerm
83 N17d92ce2e47f464fb17b494d64826097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Vinorelbine
85 rdf:type schema:DefinedTerm
86 N2d38fa66b3e44643b7e55e7fed8a0de9 schema:name dimensions_id
87 schema:value pub.1013727954
88 rdf:type schema:PropertyValue
89 N362eec552b2443bc97a70ecd8d216616 rdf:first sg:person.0731175270.26
90 rdf:rest Nba686fa93c804b8d9fbc55b098a081fc
91 N4109030ea8f74b209ef1a70fbbab12dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Vinblastine
93 rdf:type schema:DefinedTerm
94 N4bbdb25bab864357914783568c159523 rdf:first sg:person.01233253543.83
95 rdf:rest N65750acdcba84e7684cccdf6ff4067dc
96 N4f7075628f7f4124989e136ac17580eb schema:name nlm_unique_id
97 schema:value 9815755
98 rdf:type schema:PropertyValue
99 N52689fc5ec114daf814b8ce5cde7c782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Drug Resistance, Neoplasm
101 rdf:type schema:DefinedTerm
102 N53651e6fcbba4a189150e7d5b3f1bcd9 rdf:first sg:person.013501036574.15
103 rdf:rest N4bbdb25bab864357914783568c159523
104 N55fe287d9e824fc1a62bd55e4d1e1e0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Antineoplastic Combined Chemotherapy Protocols
106 rdf:type schema:DefinedTerm
107 N6425b9f4de144f5faca9b962993409d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Administration, Oral
109 rdf:type schema:DefinedTerm
110 N65750acdcba84e7684cccdf6ff4067dc rdf:first sg:person.0624412510.96
111 rdf:rest N362eec552b2443bc97a70ecd8d216616
112 N69d19207cfa9473c848290a6c9e17272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Male
114 rdf:type schema:DefinedTerm
115 N6f81cf12445b4c6a925d856a5c467b54 rdf:first sg:person.01314451274.51
116 rdf:rest Ncc2751496f084a5797c1692f59634f95
117 N73d40e9db5454e7baad92f48375f2ceb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Mitoxantrone
119 rdf:type schema:DefinedTerm
120 N774b086fb95b471ea006f27f71df67cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Prednisone
122 rdf:type schema:DefinedTerm
123 N7806f4cb234d455a8b420e97c8dab9ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Infusions, Intravenous
125 rdf:type schema:DefinedTerm
126 N7ff87d72a21b4c47b446c6d683f06d71 schema:issueNumber 1
127 rdf:type schema:PublicationIssue
128 N827b0a6010e94897b0091c3c89c9568c schema:volumeNumber 7
129 rdf:type schema:PublicationVolume
130 N8ec6c992dd334b83b47fb528f5b9ce1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Treatment Outcome
132 rdf:type schema:DefinedTerm
133 Nb626f45d44ca4231a2299287ea73d70b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Humans
135 rdf:type schema:DefinedTerm
136 Nba686fa93c804b8d9fbc55b098a081fc rdf:first sg:person.011324454444.11
137 rdf:rest N6f81cf12445b4c6a925d856a5c467b54
138 Ncc2751496f084a5797c1692f59634f95 rdf:first sg:person.01244630611.29
139 rdf:rest rdf:nil
140 Nd93c04cc36a0482d862fdc48fdd7bd75 schema:name Springer Nature - SN SciGraph project
141 rdf:type schema:Organization
142 Ne1112d56f22a45cda9fbbeeb4951a69b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Drug Administration Schedule
144 rdf:type schema:DefinedTerm
145 Ne32f8de39c6d4bfdb963a252694bd136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Prostatic Neoplasms
147 rdf:type schema:DefinedTerm
148 Ne68fd385e4fa48ed9f6830302d4468cf schema:name pubmed_id
149 schema:value 14999238
150 rdf:type schema:PropertyValue
151 Nf1989256172f465186e978f76bc6f790 schema:name readcube_id
152 schema:value 4165bde149c39a6275c8fcc9b47c38eda135c977f15577981217ca4f13e94ba6
153 rdf:type schema:PropertyValue
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
158 schema:name Clinical Sciences
159 rdf:type schema:DefinedTerm
160 sg:journal.1119336 schema:issn 1365-7852
161 1476-5608
162 schema:name Prostate Cancer and Prostatic Diseases
163 rdf:type schema:Periodical
164 sg:person.011324454444.11 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
165 schema:familyName Vaccher
166 schema:givenName E
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011324454444.11
168 rdf:type schema:Person
169 sg:person.01233253543.83 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
170 schema:familyName Talamini
171 schema:givenName R
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233253543.83
173 rdf:type schema:Person
174 sg:person.01244630611.29 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
175 schema:familyName Tirelli
176 schema:givenName U
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244630611.29
178 rdf:type schema:Person
179 sg:person.01314451274.51 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
180 schema:familyName Spina
181 schema:givenName M
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314451274.51
183 rdf:type schema:Person
184 sg:person.013501036574.15 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
185 schema:familyName Bernardi
186 schema:givenName D
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013501036574.15
188 rdf:type schema:Person
189 sg:person.0624412510.96 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
190 schema:familyName Zanetti
191 schema:givenName M
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624412510.96
193 rdf:type schema:Person
194 sg:person.0731175270.26 schema:affiliation https://www.grid.ac/institutes/grid.418321.d
195 schema:familyName Simonelli
196 schema:givenName C
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731175270.26
198 rdf:type schema:Person
199 sg:pub.10.2165/00003495-199200444-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020486322
200 https://doi.org/10.2165/00003495-199200444-00004
201 rdf:type schema:CreativeWork
202 https://app.dimensions.ai/details/publication/pub.1074562608 schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1074562609 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1079525645 schema:CreativeWork
205 https://doi.org/10.1002/1097-0142(19930201)71:3+<1098::aid-cncr2820711432>3.0.co;2-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1024352659
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1002/1097-0142(20000615)88:12+<3015::aid-cncr18>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1037280810
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r schema:sameAs https://app.dimensions.ai/details/publication/pub.1013578905
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1002/cncr.10350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021370340
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/s0094-0143(05)70066-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025793441
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/s0959-8049(02)00145-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006624855
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1023/a:1008315106697 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303095
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1023/a:1008394823889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303711
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1023/a:1011141611560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056304956
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1093/annonc/mdf029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052208075
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1097/00000421-199104000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049741912
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1097/00000421-199708000-00013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060113615
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1111/j.1399-6576.1982.tb01840.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024014172
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1200/jco.1993.11.4.607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082464109
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1200/jco.1994.12.2.360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082656922
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1200/jco.1996.14.6.1756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082896530
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1200/jco.1997.15.9.3156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083145578
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1200/jco.1999.17.11.3461 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074545753
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1200/jco.1999.17.6.1664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549748
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1200/jco.1999.17.8.2506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549873
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1200/jco.2001.19.9.2509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074807655
246 rdf:type schema:CreativeWork
247 https://doi.org/10.3322/canjclin.47.1.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049586839
248 rdf:type schema:CreativeWork
249 https://www.grid.ac/institutes/grid.418321.d schema:alternateName Centro di Riferimento Oncologico
250 schema:name Division of Medical Oncology A, Centro di Riferimento Oncologico, Aviano (PN), Italy
251 Epidemiology Unit, Centro di Riferimento Oncologico, Aviano (PN), Italy
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...